Filter
1416
Text search:
intellectual
property
Featured
Recommendations
172
New Publications
329
Language
Document type
No document type
494
Studies & Reports
318
Guidelines
274
Manuals
155
Strategic & Response Plan
96
Training Material
40
Fact sheets
27
Situation Updates
6
Resource Platforms
3
Infographics
3
Countries / Regions
Global
126
India
24
Africa
23
Ukraine
22
South–East Asia Region
22
Uganda
18
Kenya
18
Western and Central Europe
18
Ethiopia
16
Myanmar / Burma
12
East and Southern Africa
12
West and Central Africa
12
Asia
12
Ghana
11
Nigeria
10
Syria
10
South Africa
10
Eastern Europe and Central Asia
10
Liberia
9
Nepal
9
Sierra Leone
8
Zambia
8
Cambodia
8
Rwanda
8
Bangladesh
8
Malawi
8
Yemen
8
Middle East and North Africa
8
South Sudan
7
Indonesia
7
Lesotho
7
Western Pacific Region
7
Tanzania
6
Congo, Democratic Republic of
5
Zimbabwe
5
Somalia
5
Pakistan
5
Mozambique
5
Guinea
4
Haiti
4
Afghanistan
4
Sudan
4
Vietnam
4
Burkina Faso
3
Cameroon
3
Philippines
3
Jordan
3
Germany
3
Thailand
3
North Macedonia
3
Eastern Europe
3
Laos
3
Tajikistan
3
Russia
3
Iran
3
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Iraq
2
Lebanon
2
China
2
Peru
2
Colombia
2
Ecuador
2
Botswana
2
Angola
2
Latin America and the Carribbean
2
Palestine
2
Djibouti
2
Kyrgyzstan
2
Kazakhstan
2
Georgia
2
Senegal
1
Mali
1
Morocco
1
USA
1
Turkey
1
Egypt
1
Chad
1
Papua New Guinea
1
Benin
1
Namibia
1
Eswatini/ Swaziland
1
Brazil
1
Serbia
1
Bolivia
1
Greece
1
Libya
1
Mexico
1
Sri Lanka
1
Chile
1
Paraguay
1
Venezuela
1
Albania
1
Armenia
1
Mongolia
1
Timor Leste/ East Timor
1
Qatar
1
Bulgaria
1
Estonia
1
Lithuania
1
Uzbekistan
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
270
Clinical Guidelines
197
Public Health
143
Women & Child Health
114
Key Resources
87
Capacity Building
47
Pharmacy & Technologies
37
Toolboxes
Mental Health
128
HIV
127
COVID-19
109
Disability
82
TB
79
Caregiver
71
Planetary Health
68
NTDs
58
AMR
57
Rapid Response
55
Global Health Education
45
NCDs
39
Pharmacy
38
Conflict
33
Refugee
18
Health Financing Toolbox
18
Ebola
15
Natural Hazards
11
Social Ethics
11
Specific Hazards
6
Polio
5
Cholera
3
Zika
3
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the regional Transformation Agenda, which informs and aligns with the global WHO Transformation, to ensure WHO is accountable, driven by re- sults and provid
...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri
...
What are the FP and CAC competencies?
Through the clear articulation of the family planning and comprehensive abortion care (FP and CAC) competencies for the primary health care workforce, the aim is to advance improvements in FP and CAC service delivery by aligning health worker education approach
...
This document, Programme and curriculum development guide, presents a systematic approach to developing programmes and curricula for implementation of the family planning (FP) and comprehensive abortion care (CAC) competencies,and the theory behind the approach. Specifically, the aim is for effectiv
...
Obesity and diet-related noncommunicable diseases (NCDs) have been steadily increasing globally, and with them, a pressing need to implement effective responses to address the contributing factors. Among the available evidence-based policy options that enable healthier choices and improved diets is
...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat
...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da
...
The COVID-19 pandemic has raised profound ethical challenges on an unprecedented global scale. These challenges include how to allocate scarce resources (especially vaccines and therapeutics), both within and between countries, whether and when to mandate vaccines and/or masks, whether and how to co
...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each formerly endemic EU. Usi
...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d
...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres
...
The HHFA Comprehensive guide serves as the main reference document for planning and implementing a country HHFA. This guide will promote understanding of:
What the HHFA is and the information it can and cannot provide.
The HHFA modules, questionnaires and CSPro electronic data collection tool.
Th
...
International commitment to eliminate trachoma as a public health problem worldwide is supported by resolution WHA51.11 of the World Health Assembly .1 Important progress towards this goal has been made by harnessing the mostly informal relationships that exist between partners including Member Stat
...
SECOND MEETING REPORT
DECATUR, GA, USA, 26 JUNE 2016
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan
...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for
...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la
...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r
...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t
...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
